ABSTRACT

The drug discovery and development process is getting longer, more expensive, and no better. The industry suffers from the same clinical attrition and safety-related market withdrawal rates today as it did 20 years ago. Industrialization of Drug Discovery: From Target Selection Through Lead Optimization scrutinizes these problems in detail, contras

chapter 2|18 pages

The Regulatory Age

chapter 3|26 pages

Industrialization, Not Automation

chapter 4|46 pages

Compound Management

chapter 7|26 pages

Knowledge Management